Diary Prequel Package — page 387

K) ma, thorn Subject: SPL 14.066 samples from 21 October 2014 (UNCLASSIFIED) Date: Tuesday, October 21, 2014 at 5:52:15 PM Eastern Daylight Time From: Dorman, William R (Bill) CIV USARMY MEDCOM USAMRIID (US) To: "RDAVEY @niaid.nih.gov' ce: 'CLANE@niaid.nih.gov', Wolcott, Mark J CIV USARMY MEDCOM USAMRIID (US), Tostenson, Samantha D CIV USARMY MEDCOM USAMRIID (US) Classification: UNCLASSIFIED Caveats: NONE Dr. Davey, This concerns results on samples submitted under SPL14.066 from 21 October 2014. SPL14.066.07 (whole blood) was NEGATIVE for the presence of Ebola glycoprotein RNA with the EZ1 RT-PCR assay (EUA). SPL14.066.07 was NEGATIVE for the presence of Ebola nucleocapsid protein RNA with an Ebola RT-PCR assay (LDT). SPL14.066.08 (serum) Ebola serology - PENDING (RUO) SPL14.066.09 (Throat Swab) was NEGATIVE for the presence of both Ebola glycoprotein RNA and Ebola nucleocapsid protein RNA with an Ebola RT-PCR assay (RUO) SPL14.066.10 (Rectal Swab) was NEGATIVE for the presence of both Ebola glycoprotein RNA and Ebola nucleocapsid protein RNA with an Ebola RT-PCR assay (RUO) SPL14.066.11 (Urine) was NEGATIVE for the presence of both Ebola glycoprotein RNA and Ebola nucleocapsid protein RNA with an Ebola RT-PCR assay (RUO) SPL14.066.12 (Vaginal secretion) was NEGATIVE for the presence of both Ebola glycoprotein RNA and Ebola nucleocapsid protein RNA with an Ebola RT-PCR assay (RUO) There will be an official hardcopy report rendered when all testing is completed. This email can be treated as an interim report. If there are any questions on the testing or results, please feel free to contact me. V/R, Bill Dorman Bio-Threat Coordinator Special Pathogens Laboratory Diagnostic Systems Division No press today since HHS and White House wanted nothing on but the announcement of the new PPEs by CDC and the DHS announcement of the 5 airports only.